AzTrials
AzTrials

StressPOSSAIDNCT04909970

Impact of a Self-hyPnOsis Practice on Chronic StresS Among Caregivers of Elderly People With Loss of Autonomy at Home

A study testing Self-hypnosis in people with Stress, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In France, stress particularly affects family caregivers because of the intensive help they provide on a permanent basis to people losing their autonomy at home. This care work is often considered as a "burden" and has all the characteristics of a chronic daily stress factor. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Stress
What is being tested?
Self-hypnosis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteReunion
Study dates
10 Apr 2025to 27 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Stress > or = 3 evaluated by the analogic visual scale of CHAMOUX
  • Caregiver at home for a person uper than 60 years old with a loss of autonomy and followed in geriatrics or in polyvalent medicine
  • Daily help in at least one of the 3 spheres of the elderly activity
  • Person providing care services for more than 2 years with the elderly
  • Person who can read and write
  • Person affiliated to a social security scheme
  • Person who gives his oral express consent
  • Person who lives in Reunion Island

Who cannot join

  • Person with serious chronic disorder (cancer for example)
  • Person with a contraindication to hypnosis (cognitive and psychiatric disorders or alcohol dependence)
  • Person under specific treatment preventing them from performing the intervention consistently
  • Person who has already practiced hypnosis

Trial locations and contacts

1 site in 1 country.

Reunion1 site
  • CHU de La Réunion

    Saint-Pierre

Other trials in Reunion

About this study

Official title: Impact of a Self-hyPnOsis Practice on Chronic StresS Among Caregivers of Elderly People With Loss of Autonomy at Home: a Randomized Controlled Pilot Study With a Waiting List

In France, stress particularly affects family caregivers because of the intensive help they provide on a permanent basis to people losing their autonomy at home. This care work is often considered as a "burden" and has all the characteristics of a chronic daily stress factor. The prevalence of stress among caregivers is high and the level of stress varies according to the type of care provided to seniors at home.

This chronic stress has harmful effects on the health of family caregivers (depression, fatigue, insomnia, onset of chronic diseases, early mortality). It can be detrimental to their well-being and quality of life.

Read more

However, ageing well at home for older people is based on this essential pillar: the caregivers. They must remain in good physical and psychological health. Reducing their daily stress is becoming a public health challenge and a national priority.

Currently, the management of caregiver stress is based on several measures and devices. Non-conventional care practices such as Mindfulness-Based Stress Reduction, meditation, relaxation and yoga are offered to family caregivers. Initial results of studies on the effect of these complementary medicines show an improvement in psychological stress. However, research in this field is relatively recent. The conclusions must therefore be approached with caution. Moreover, no medium or long-term evaluation has been found in the scientific literature.

Self-hypnosis is becoming a common practice in healthcare. It has demonstrated its effectiveness in reducing pain and anxiety in both adults and children. In addition, other recent scientific evidence supports the effectiveness of hypnosis in stress management. In France, no study on caregiver stress and its management by self-hypnosis has been identified in the literature. The hypothesis is that the stress level of caregivers of elderly people at home could be reduced through daily self-hypnosis practice at home.

Conditions
Stress
Being tested
Self-hypnosis, Control (Waiting list)
Keywords
Family caregivers, Aged persons, homebound persons, Chronic stress, Self-hypnosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-hypnosisOther

    Self-hypnosis training during 8 weeks and one daily self-hypnosis session during 8 weeks

  • Control (Waiting list)Other

    Usual practice during the first 16 weeks. At the end of study, the participant will practice Self-hypnosis training during 8 weeks and one daily self-hypnosis session during 8 weeks

Study groups in NCT04909970
Study groupRoleWhat they receive
Self hypnosisExperimentalSelf-hypnosis program associated to usual practice of stress management
Receives: Other: Self-hypnosis
control group (waiting list)OtherUsual practice of stress management. This group will practice self-hypnosis after the intervention group has practiced self-hypnosis (waiting list).
Receives: Other: Control (Waiting list)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of the feasibility of a practice of self-hypnosis on reducing the stress of carers caring for the elderly at home compared to a control group with waiting list.

    Membership of program participants : number of session of self-hypnosis realized compared to proposed session.

    It will be considered sufficient if 80% of the participants carry out 2 individual sessions and 1 collective hypnosis session during the training and practice 80% of the self-hypnosis sessions at home.

    Measured: week 16 after enrollment

  2. Assessment of the feasibility of a practice of self-hypnosis on reducing the stress of carers caring for the elderly at home compared to a control group with waiting list.

    number of patients recruited over 6 months Recruitment will be deemed acceptable if 60 participants are recruited over 6 months.

    Measured: 6 months after the first enrollment

Secondary outcomes (10)
  1. Comparison of the variation in caregiver burden between inclusion and the end of self-hypnosis practice between the 2 groups of participant

    The burden will be evaluated by the Zarit scale min score = 0 and max score =88 score>60 = serious burden

    Measured: week 16 after enrollment

  2. Comparison of the variation in caregiver sleep quality between inclusion and the end of selfhypnosis practice between the 2 groups of participant

    The quality of sleep will be evaluated by the Pittsburgh Sleep Quality Index (PSQI) min score = 0 and max score = 32 score = 32 : extreme fatigue

    Measured: week 16 after enrollment

  3. Comparison of the variation in caregiver fatigue level between inclusion and the end of self-hypnosis practice between the 2 groups of participant

    The level of fatigue will be evaluated by the Pichot scale

    Measured: week 16 after enrollment

  4. Comparison of the variation in caregiver quality of life between inclusion and the end of self-hypnosis practice between the 2 groups of participant

    Quality of life will be evaluated by the SF-12 scale Score calculated with a software

    Measured: week 16 after enrollment

  5. Comparison between the 2 groups the care consumption between inclusion and the end of self-hypnosis practice

    The care consumption will collected on a patient diary.

    Measured: week 16 after enrollment

  6. Observance of self-hypnosis sessions at home

    Duration and localization of the session will be collected on a patient diary.

    Measured: week 8 after enrollment

  7. Observance of self-hypnosis sessions at home

    Duration and localization of the session will be collected on a patient diary.

    Measured: week 16 after enrollment

  8. Observance of self-hypnosis sessions at home

    Duration of the session will be collected on a patient diary.

    Measured: week 32 after enrollment

  9. Observance of self-hypnosis sessions at home

    Localization of the session will be collected on a patient diary.

    Measured: week 32 after enrollment

  10. Comparison of the variation of perceived stress between inclusion and the end of self-hypnosis practice between the 2 groups of participant

    Stress will be evaluated by the Perceived Stress Scale (PSS) min score = 10 and max score = 50 score < 27 : stress management by the person

    Measured: week 16 after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2021
  2. Study start10 Apr 2025
  3. Primary completion27 Nov 2025
  4. Study completion27 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
waiting list
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04909970
Sponsor's protocol ID
2021/CHU/02
Acronym
POSSAID
Status last verified
Mar 2026
First submitted
3 May 2021
Last updated
13 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Reynaud D, Bruneau L. Feasibility and acceptance of self-hypnosis to reduce chronic stress levels on family in-home caregivers of elderly people: protocol for the POSSAID pilot, randomised, wait-list controlled trial. BMJ Open. 2022 Dec 30;12(12):e066749. doi: 10.1136/bmjopen-2022-066749.

    PubMed 36585135

Questions about this trial

What is this clinical trial studying?

A study testing Self-hypnosis in people with Stress, run by Centre Hospitalier Universitaire de la Réunion at 1 site in Reunion.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Reunion. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of the feasibility of a practice of self-hypnosis on reducing the stress of carers caring for the elderly at home compared to a control group with waiting list. (time frame: week 16 after enrollment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04909970, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in